
Tarak Srivastava MD
Associate Professor, Pediatrics, University of Missouri, Kansas City School of Medicine
Join to View Full Profile
2401 Gillham RdKansas City, MO 64108
Phone+1 816-234-3010
Fax+1 816-234-3494
Dr. Srivastava is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children’s Mercy HospitalFellowship, Pediatric Nephrology, 1997 - 2000
Seth G.S. Medical CollegeClass of 1991
Certifications & Licensure
CA State Medical License 2002 - Present
MO State Medical License 2001 - 2027
KS State Medical License 2003 - 2026
American Board of Pediatrics Pediatric Nephrology
Clinical Trials
- Atorvastatin (Lipitor) to Prevent Bone Pain Start of enrollment: 2004 Dec 01
- Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 1 citationsPolygenic risk scores and HLA class II variants are biomarkers of corticosteroid response in childhood nephrotic syndrome.Tiffany Tu, Alejandro Ochoa, Amika Sood, Ashley Dabrik, Megan Chryst-Stangl
Kidney International. 2026-06-01 - Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients With Idiopathic Nephrotic Syndrome.Sarah K Nelson-Taylor, Jonathan Troost, Courtney Giannini, Colin Bauer, Tarak Srivastava
Kidney Medicine. 2026-03-01 - 1 citationsEndothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.Colin Bauer, Federica Piani, Jonathan Troost, Stefano Da Sacco, Guadalupe Rojas-Sanchez
Science Translational Medicine. 2026-01-14
Journal Articles
- Adrenocorticotropic Hormone for Childhood Nephrotic SyndromeAlejandro Quiroga, Mark R Benfield, Carlos E Araya, Tarak Srivastava, Joshua Zaritsky, Rasheed Gbadegesin, Ora Yadin, Myda Khalid, Alvaro Orjuela, Guillermo Hidalgo, M..., Journal of the American Society of Nephrology
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology
- Recurrence of Nephrotic Syndrome Following Kidney Transplantation Is Associated with Initial Native Kidney Biopsy FindingsKeisha Gibson, Tarak Srivastava, John W. Foreman, David Selewski, John Barcia, Shashi K. Nagaraj, Patricia Weng, Karan R. Kumar, Adam Bensimhon, Scot E. Wenderfer, Chr..., Pediatric Nephrology
Other
- Bone metabolism and renal osteodystrophy in children with chronic kidney diseaseSrivastava T, Warady BA
http://www.uptodate.com/contents/bone-metabolism-and-renal-osteodystrophy-in-children-with-chronic-k
UpToDate, Wolters Kluwer Health - 2012-05-14 - Clinical presentation and evaluation of chronic kidney disease in childrenSrivastava T, Warady BA, Wong CS
http://www.uptodate.com/contents/clinical-presentation-and-evaluation-of-chronic-kidney-disease-in-c
UpToDate, Wolters Kluwer Health - 2012-05-09 - Overview of the management of chronic kidney disease in childrenSrivastava T, Warady BA
http://www.uptodate.com/contents/overview-of-the-management-of-chronic-kidney-disease-in-children
UpToDate, Wolters Kluwer Health - 2013-03-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









